# Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder

> **NCT01919008** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 16 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** FK949E

## Key facts

- **NCT ID:** NCT01919008
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03-26
- **Primary completion:** 2012-06-22
- **Final completion:** 2012-06-22
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01919008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01919008, "Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01919008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*